The Democratic Republic of Congo introduced a new second vaccine against the Ebola virus.
The new vaccine was developed by Johnson & Johnson to protect people against the virus.
Different areas of the Democratic Republic of Congo have been fighting against the epidemic and has since then led to over 2,000 deaths.
The authorities have already placed preventive measures since last year with more than 250,000 people who have already been vaccinated with other anti-Ebola vaccines.
The MSF (Médecins Sans Frontières) of the Democratic Republic of Congo said that those people that received the first batch of doses will have to return for the second dose of the new vaccine to ensure that maximum protection against the virus is achieved.
This measure hopes to study the success of having two doses of vaccination against the Ebola virus.